Neuropeptide Y (NPY) and depression: From animal studies to the human condition

Life Sciences

Volumn 71, Issue 25, 2002, Pages 2921-2937

  Redrobe, John P ^a   Dumont, Yvan ^a   Quirion, Rémi ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Clinical evidence; Depression; Neuropeptide Y; Pre clinical evidence

Indexed keywords

2 [1 (3 CHLORO 5 ISOPROPOXYCARBONYLAMINOPHENYL)ETHYLAMINO] 6 [2 (5 ETHYL 4 METHYL 2 THIAZOLYL)ETHYL] 4 MORPHOLINOPYRIDINE; CGP 71683 A; FLUOXETINE; G 1264879 A; GR 231118; IMIPRAMINE; J 104870; L 152804; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; N [2 [1,2 DIHYDRO 3,5(4H) DIOXO 1,2 DIPHENYL 1,2,4 TRIAZOL 4 YL]ETHYL] N2 [[1 [2 [4 [5,11 DIHYDRO 6(6H) OXODIBENZ[B,E]AZEPIN 11 YL] 1 PIPERAZINYL] 2 OXOETHYL]CYCLOPENTYL]ACETYL]ARGININAMIDE; N2 DIPHENYLACETYL N (4 UREIDOMETHYLBENZYL)ARGININAMIDE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y [13-36]; NEUROPEPTIDE Y [31 LEUCINE 34 PROLINE]; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y3 RECEPTOR; NEUROPEPTIDE Y4 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; NEUROPEPTIDE Y[34 PROLINE]; NORADRENALIN UPTAKE INHIBITOR; PEPTIDE DERIVATIVE; PEPTIDE YY[13-36]; PEPTIDE YY[31 LEUCINE 34 PROLINE]; PEPTIDE YY[34 PROLINE]; REBOXETINE; RECEPTOR SUBTYPE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VENLAFAXINE;

AUTOPSY; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; DEPRESSION; DISEASE ASSOCIATION; DISEASE MODEL; ELECTROCONVULSIVE THERAPY; EMOTION; EXPERIMENTAL RAT; FORCED SWIMMING TEST; GENETIC MODEL; GENETICS; HUMAN; IMMUNOREACTIVITY; LIMBIC SYSTEM; MATERNAL DEPRIVATION; MENTAL DISEASE; NEUROMODULATION; NONHUMAN; OLFACTORY BULBECTOMY; PATHOGENESIS; PHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PSYCHOSOCIAL CARE; REGULATORY MECHANISM; SHORT SURVEY; SUICIDE; THROMBOCYTE; TISSUE DISTRIBUTION; TRANSCRANIAL MAGNETIC STIMULATION; VAGUS NERVE STIMULATION;

ANIMALS; BIOMEDICAL RESEARCH; BRAIN; DEPRESSION; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; HUMANS; NEUROPEPTIDE Y; RECEPTORS, NEUROPEPTIDE Y;

ANIMALIA;

EID: 0037044697     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)02159-8     Document Type: Short Survey

References (122)

1. Wittchen H.U., Knauper B., Kessler R.C. Lifetime risk of depression. British Journal of Psychiatry. Suppl. 26:1994;16-22.
2. Berto P., D'Ilario D., Ruffo P., DiVirgilio R., Rizzo F. Depression: cost-of-illness studies in the international literature, a review. The Journal of Mental Health Policy and Economics. 3(1):2000;3-10.
3. Olver J.S., Burrows G.D., Norman T.R. Third-generation antidepressants: do they offer advantages over the SSRIs? CNS Drugs. 15(2):2001;941-954.
4. Kornstein S.G., Schneider R.K. Clinical features of treatment-resistant depression. Journal of Clinical Psychiatry. 62(Suppl. 16):2001;18-25.
5. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron. 34(1):2002;13-25.
6. Stanley B.G., Leibowitz S.F. Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sciences. 35(26):1984;2635-2642.
7. Flood J.F., Hernandez E.N., Morley J.E. Modulation of memory processing by neuropeptide Y. Brain Research. 421(1-2):1987;280-290.
8. Redrobe J.P., Dumont Y., St-Pierre J.A., Quirion R. Multiple receptors for neuropeptide Y in the hippocampus: putative roles in seizures and cognition. Brain Research. 848(1-2):1999;153-166.
9. Colmers W.F., Bleakman D. Effects of neuropeptide Y on the electrical properties of neurons. Trends in Neuroscience. 17(9):1994;373-379.
10. Vezzani A., Sperk G., Colmers W.F. Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends in Neuroscience. 22(1):1999;25-30.
11. Small C.J., Morgan D.G., Meeran K., Heath M.M., Gunn I., Edwards C.M.et al. Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone release. Proceedings of the National Academy of Science USA. 94(21):1997;11686-11691.
12. Catzeflis C., Pierroz D.D., Rohner-Jeanrenaud F., Rivier J.E., Sizonenko P.C., Aubert M.L. Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in intact adult female rats. Endocrinology. 132(1):1993;224-234.
13. Heilig M., Wahlestedt C., Ekman R., Widerlov E. Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain. European Journal of Pharmacology. 147(3):1988;465-467.
14. Michel M.C., Beck-Sickinger A., Cox H., Doods H.N., Herzog H., Larhammar D.et al. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacological Reviews. 50(1):1998;143-150.
15. Larhammar D. Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide. Regulatory Peptides. 62(1):1996;1-11.
16. Elshourbagy N.A., Ames R.S., Fitzgerald L.R., Foley J.J., Chambers J.K., Szekeres P.G., Evans N.A.et al. Receptor for the pain modulatory peptides FF and AF is an orphan G protein-coupled receptor. Journal of Biological Chemistry. 275(34):2000;25965-25971.
17. Bonini J.A., Jones K.A., Adham N., Forray C., Artymyshyn R., Durkin M.M., Smith K.E.et al. Identification and characterization of two G protein-coupled receptors for neuropeptide FF. Journal of Biological Chemistry. 275(50):2000;39324-39331.
18. Parker R., Liu M., Eyre H.J., Copeland N.G., Gilbert D.J., Crawford J., Sutherland G.R.et al. Y-receptor-like-genes GPR72 and GPR73: molecular cloning, genomic organisation and assignment to human chromosome 11q21.1 and 2p14 and mouse chromosome 9 and 6. Biochimica et Biophysica Acta. 1491(1-3):2000;369-375.
19. Eva C., Keinanen K., Monyer H., Seeburg P., Sprengel R. Molecular cloning of a novel G protein-coupled receptor that may belong to the neuropeptide receptor family. FEBS Letters. 271(1-2):1990;81-84.
20. Krause J., Eva C., Seeburg P.H., Sprengel R. Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor. Molecular Pharmacology. 41(5):1992;817-821.
21. Herzog H., Hort Y.J., Ball H.J., Hayes G., Shine J., Selbie L.A. Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proceedings of the National Academy of Science USA. 89(13):1992;5794-5798.
22. Larhammar D., Blomqvist A.G., Yee F., Jazin E., Yoo H., Wahlestedt C. Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. Journal of Biological Chemistry. 267(16):1992;10935-10938.
23. Eva C., Oberto A., Sprengel R., Genazzani E. The murine NPY-1 receptor gene. Structure and delineation of tissue-specific expression. FEBS Letters. 314(3):1992;285-288.
24. Nakamura M., Sakanaka C., Aoki Y., Ogasawara H., Tsuji T., Kodama H., Matsumoto T.et al. Identification of two isoforms of mouse neuropeptide Y-Y1 receptor generated by alternative splicing. Isolation, genomic structure, and functional expression of the receptors. Journal of Biological Chemistry. 270(50):1995;30102-30110.
25. Berglund M.M., Holmberg S.K., Eriksson H., Gedda K., Maffrand J.P., Serradeil-La Gal C., Chhajlani V., Grundemar L., Larhammar D. The cloned guinea pig neuropeptide Y receptor Y1 conforms to other mammalian Y1 receptors. Peptides. 20(9):1999;1043-1053.
26. Malmstrom R.E., Hokfelt T., Bjorkman J.A., Nihlen C., Bystrom M., Ekstrand A.J., Lundberg J.M. Characterization and molecular cloning of vascular neuropeptide Y receptor subtypes in pig and dog. Regulatory Peptides. 75-76:1998;55-70.
27. Gehlert D.R., Yang P., George C., Wang Y., Schober D., Gackenheimer S., Johnson D., Beavers L.S., Gadski R.A., Baez M. Cloning and characterization of Rhesus monkey neuropeptide Y receptor subtypes. Peptides. 22(3):2001;343-350.
28. Tong Y., Dumont Y., Shen S.H., Quirion R. Comparative developmental profile of the neuropeptide Y Y1 receptor gene and protein in the rat brain. Molecular Brain Research. 48(2):1997;323-332.
29. Dumont Y., Fournier A., St-Pierre S., Schwartz T.W., Quirion R. Differential distribution of neuropeptide Y1 and Y2 receptors in the rat brain. European Journal of Pharmacology. 191(3):1990;501-503.
30. Dumont Y., Fournier A., St-Pierre S., Quirion R. Autoradiographic distribution of [125I][Leu31,Pro34]PYY and [125I]PYY-3-36 binding sites in the rat brain evaluated with two newly developed Y1 and T2 receptor radioligands. Synapse. 22(2):1996;139-158.
31. Jacques D., Dumont Y., Fournier A., Quirion R. Characterization of neuropeptide Y receptor subtypes in the normal human brain, including the hypothalamus. Neuroscience. 79(1):1997;129-148.
32. Dumont Y., Jacques D., Bouchard P., Quirion R. Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains. Journal of Comparative Neurology. 402(3):1998;372-384.
33. Rose P.M., Fernandes P., Lynch J.S., Frazier S.T., Fisher S.M., Kodukula K., Kienzle B., Seethala R. Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. Journal of Biological Chemistry. 270(39):1995;22661-22664.
34. 2 receptor subtype. Journal of Biological Chemistry. 270(45):1995;26758-26761.
35. Gehlert D.R., Beavers L.S., Johnson D., Gackenheimer S.L., Schober D.A., Gadski R.A. Expression cloning of a human brain neuropeptide Y Y2 receptor. Molecular Pharmacology. 49(2):1996;224-228.
36. St-Pierre J.A., Dumont Y., Nouel D., Herzog H., Hamel E., Quirion R. Preferential expression of the neuropeptide Y Y1 over the Y2 receptor subtype in cultured hippocampal neurons and cloning of the rat Y2 receptor. British Journal of Pharmacology. 123(2):1998;183-194.
37. Ammar D.A., Eadie D.M., Wong D.J., Ma Y.Y., Kolakowski L.F. Jr., Yang-Feng T.L., Thompson D.A. Characterization of the human type 2 neuropeptide Y receptor gene (NPY2R) and localization to the chromosome 4q region containing the type 1 neuropeptide Y receptor gene. Genomics. 38(3):1996;392-398.
38. Nakamura M., Aoki Y., Hirano D. Cloning and functional expression of a cDNA encoding a mouse type 2 neuropeptide Y receptor. Biochimica et Biophysica Acta. 1284(2):1996;134-137.
39. Dumont Y., Jacques D., St-Pierre J.A., Tong Y., Parker R., Herzog H., Quirion R. Neuropeptide, Y, peptide YY and pancreatic polypeptide receptor proteins and mRNAs in mammalian brains. Quirion R., Bjorklund A., Hokfelt T. Handbook of Chemical Neuroanatomy. 2000;375-475 Elsevier, London.
40. Grundemar L., Wahlestedt C., Reis D.J. Neuropeptide Y acts as an atypical receptor to evoke cardiovascular depression and to inhibit glutamate responsiveness in the brainstem. Journal of Pharmacology and Experimental Therapeutics. 258(2):1991;633-638.
41. Dumont Y., Cadieux A., Pheng L.H., Fournier A., St-Pierre S., Quirion R. Peptide YY derivatives as selective neuropeptide Y/peptide YY Y1 and Y2 agonists devoided of activity for the Y3 receptor sub-type. Molecular Brain Research. 26(1-2):1994;320-324.
42. Hirabayashi A., Nishiwaki K., Shimada Y., Ishikawa N. Role of neuropeptide Y and its receptor subtypes in neurogenic pulmonary edema. European Journal of Pharmacology. 296(3):1996;297-305.
43. Wahlestedt C., Regunathan S., Reis D.J. Identification of cultured cells selectively expressing Y1-, Y2-, or Y3-type receptors for neuropeptide Y/peptide YY. Life Sciences. 50(4):1992;PL7-PL12.
44. Rimland J., Xin W., Sweetnam P., Saijoh K., Nestler E.J., Duman R.S. Sequence and expression of a neuropeptide Y receptor cDNA. Molecular Pharmacology. 40(6):1991;869-875.
45. Herzog H., Hort Y.J., Shine J., Selbie L.A. Molecular cloning, characterization, and localization of the human homologue to the reported bovine NPY Y3 receptor: lack of NPY binding and activation. DNA Cell Biology. 12(6):1993;465-471.
46. Feng Y., Broder C.C., Kennedy P.E., Berger E.A. HIV-1 entry factor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 272(5263):1996;872-877.
47. Gehlert D.R., Schober D.A., Beavers L., Gadski R., Hoffman J.A., Smiley D.L., Chance R.E., Lundell I., Larhammar D. Characterization of the peptide binding requirements for the cloned pancreatic polypeptide-preferring receptor. Molecular Pharmacology. 50(1):1996;112-118.
48. Bard J.A., Walker M.W., Branchek T.A., Weinshank R.L. Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY. Journal of Biological Chemistry. 270(45):1995;26762-26765.
49. Gregor P., Feng Y., DeCarr L.B., Cornfield L.J., McCaleb M.L. Molecular characterization of a second mouse pancreatic polypeptide receptor and its inactivated human homologue. Journal of Biological Chemistry. 271(44):1996;27776-27781.
50. Lundell I., Statnick M.A., Johnson D., Schober D.A., Starback P., Gehlert D.R., Larhammar D. The cloned rat pancreatic polypeptide receptor exhibits profound differences to the orthologous receptor. Proceedings of the National Academy of Science USA. 93(10):1996;5111-5115.
51. Eriksson H., Berglund M.M., Holmberg S.K., Kahl U., Gehlert D.R., Larhammar D. The cloned guinea pig pacreatic polypeptide receptor Y4 resembles more the human Y4 than does the rat Y4. Regulatory Peptides. 75-76:1998;29-37.
52. Parker R.M., Herzog H. Regional distribution of Y-receptor subtype mRNAs in rat brain. European Journal of Neuroscience. 11(4):1999;1431-1448.
53. Trinh T., Dumont Y., Quirion R. High levels of specific neuropeptide Y/pancreatic polypeptide receptors in the rat hypothalamus and brainstem. European Journal of Pharmacology. 318(1):1996;R1-R3.
54. 34-PYY is a high affinity radioligand for rat PP1/Y4 and Y1 receptors: evidence for heterogeneity in pancreatic polypeptide receptors. Peptides. 18(3):1997;397-401.
55. Jolicoeur F.B., Michaud J.N., Menard D., Fournier A. In vivo structure activity study supports the existence of heterogeneous neuropeptide Y receptors. Brain Research Bulletin. 26(2):1991;309-311.
56. Hu Y., Bloomquist B.T., Cornfield L.J., DeCarr L.B., Flores-Riveros J.R., Friedman L., Jiang P.et al. Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior. Journal of Biological Chemistry. 271(42):1996;26315-26319.
57. Nakamura M., Yokoyama M., Watanabe H., Matsumoto T. Molecular cloning, organizationand localization of the gene for the mouse neuropeptide Y-Y5 receptor. Biochimica et Biophysica Acta. 1328(2):1997;83-89.
58. Borowsky B., Walker M.W., Bard J., Weinshank R.L., Laz T.M., Vaysse P., Branchek T.A., Gerald C. Molecular biology and pharmacology of multiple NPY Y5 receptor species homologs. Regulatory Peptides. 75-76:1998;45-53.
59. Lundell I., Eriksson H., Marklund U., Larhammar D. Cloning and characterization of the guinea pig neuropeptide Y receptor Y5. Peptides. 3(3):2001;357-363.
60. Jacques D., Tong Y., Shen S.H., Quirion R. Discrete distribution of the neuropeptide Y Y5 receptor gene in the human brain: an in situ hybridization study. Molecular Brain Research. 61(1-2):1998;100-107.
61. Weinberg D.H., Sirinathsinghji D.J., Tan C.P., Shiao L.L., Morin N., Rigby M.R., Heavens R.H.et al. Cloning and expression of a novel neuropeptide Y receptor. Journal of Biological Chemistry. 271(28):1996;16435-16438.
62. Matsumoto M., Nomura T., Momose K., Ikeda Y., Kondou Y., Akiho H., Togami J.et al. Inactivation of a novel neuropeptide Y/peptide YY receptor gene in primate species. Journal of Biological Chemistry. 271(44):1996;27217-27220.
63. Burkhoff A., Linemeyer D.L., Salon J.A. Distribution of a novel neuropeptide Y receptor gene and its absence in rat. Molecular Brain Research. 53(1-2):1998;311-316.
64. Starback P., Wraith A., Eriksson H., Larhammar D. Neurpeptide Y receptor gene y6: multiple deaths or resurrections? Biochemical and Biophysical Research Communications. 277(1):2000;264-269.
65. Wraith A., Tornsten A., Chardon P., Harbitz I., Chowdhary B.P., Andersson L., Lundin L.G., Larhammar D. Evolution of the neuropeptide Y receptor family: gene and chromosome duplications deduced from the cloning and mapping of the five receptor subtype genes in pig. Genome Research. 10(3):2000;302-310.
66. Dumont Y., Fournier A., St-Pierre S., Quirion R. Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain. Journal of Neuroscience. 13(1):1993;73-86.
67. Tatemoto K., Carlquist M., Mutt V. Neuropeptide Y- a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature. 296(5858):1982;659-660.
68. Stenfors C., Mathé A.A., Theodorsson E. Chromatographic and immunochemical characterization of rat brain neuropeptide Y-like immunoreactivity (NPY-LI) following repeated electroconvulsive stimuli. Journal of Neuroscience Research. 41(2):1995;206-212.
69. Zachrisson O., Mathé A.A., Stenfors C., Lindefors N. Limbic effects of repeated electroconvulsive stimulation on neuropeptide Y and somatostatin mRNA expression in the rat brain. Molecular Brain Research. 31(1-2):1995;71-85.
70. Mikkelsen J.D., Woldbye D., Kragh J., Larsen P.J., Bolwig T.G. Electroconvulsive shocks increase the expression of neuropeptide Y (NPY) mRNA in the piriform cortex and the dentate gyrus. Molecular Brain Research. 23(4):1994;317-322.
71. Husum H., Mikkelsen J.D., Hogg S., Mathé A.A., Mork A. Involvement of hippocampal neuropeptide Y in mediating the chronic actions of lithium, electroconvulsive stimulation and citalopram. Neuropharmacology. 39(8):2000;1463-1473.
72. Zachrisson O., Mathé A.A., Stenfors C., Lindefors N. Region-specific effects of chronic lithium administration on neuropeptide Y and somatostatin mRNA expression in the rat brain. Neuroscience Letters. 194(1-2):1995;89-92.
73. Caberlotto L., Fuxe K., Overstreet D.H., Gerrard P., Hurd Y.L. Alterations in neuropeptide Y and Y1 receptor mRNA expression in brains from an animal model of depression: region specific adaptation after fluoxetine treatment. Molecular Brain Research. 59(1):1998;58-65.
74. Widdowson P.S., Halaris A.E. Chronic desipramine treatment reduces regional neuropeptide Y binding to Y2-type receptors in rat brain. Brain Research. 539(2):1991;196-202.
75. Heilig M., Ekman R. Chronic parenteral antidepressant treatment in rats: unaltered levels of neuropeptide Y (NPY) and corticotrophin-releasing hormone (CRH). Neurochemistry International. 26(4):1995;351-355.
76. Caberlotto L., Jimenez P., Overstreet D.H., Hurd Y.L., Mathe A.A., Fuxe K. Alterations in neuropeptide Y levels and Y1 binding sites in the Flinders Sensitive rats, a genetic animal model of depression. Neuroscience Letters. 265(3):1999;191-194.
77. Overstreet D.H. The Flinders sensitive line rats: a genetic animal model of depression. Neuroscience and Biobehavioral Reviews. 17(1):1993;51-68.
78. Overstreet D.H., Russel R.W. Selective breeding for sensitivity to DFP. Effects of cholinergic agonists and antagonists. Psychopharmacology. 78(2):1982;150-154.
79. Shiromani P.J., Overstreet D.H., Levy D., Goodrich C.A., Campbell S.S., Gillin J.C. Increased REM sleep in rats selectively bred for cholinergic hyperactivity. Neuropsychopharmacology. 1(2):1988;127-133.
80. Pucilowski O., Overstreet D.H., Rezvani A.H., Janowski D.S. Chronic mild stress-induced anhedonia: greater effect in a genetic animal model of depression. Physiology and Behavior. 54(6):1993;1215-1220.
81. Jimenez-Vasquez P.A., Overstreet D.H., Mathé A.A. Neuropeptide Y in male and female brains of Flinders Sensitive Line, a rat model of depression. Effects of electroconvulsive stimuli. Journal of Psychiatric Research. 34(6):2000;405-412.
82. Aulakh C.S., Hill J.L., Murphy D.L. Attenuation of hypercortisolemia in Fawn-Hooded rats by antidepressant drugs. European Journal of Pharmacology. 240(1):1993;85-88.
83. Aulakh C.S., Tolliver T., Wozniak K.M., Hill J.L., Murphy D.L. Functional and biochemical evidence for altered serotonergic function in the Fawn-Hooded rat strain. Pharmacology Biochemistry and Behavior. 49(3):1994;615-620.
84. Aulakh C.S., Mazzola-Pomieto P., Murphy D.L. Long-term antidepressant treatments alter 5-HT2A and 5-HT2C receptor-mediated hyperthermia in Fawn-Hooded rats. European Journal of Pharmacology. 282(1-3):1995;65-70.
85. Hulihan-Giblin B.A., Park Y.D., Goldman D., Aulakh C.S. Analysis of 5-HT1C receptor and the serotonin uptake site in Fawn-Hooded rat brain. European Journal of Pharmacology. 239(1-3):1993;99-102.
86. Overstreet D.H., Rezvani A., Janowsky D.S. Genetic animal models of depression and ethanol preference provide support for cholinergic and serotonergic involvement in depression and alcoholism. Biological Psychiatry. 31(9):1992;919-936.
87. Mathé A.A., Jimenez P.A., Theodorsson E., Stenfors C. Neuropeptide Y, neurokinin A and neurotensin in brain regions of Fawn-Hooded "depressed", Wistar, and Sprague-Dawley rats. Effects of electroconvulsive stimuli. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 22(3):1998;529-546.
88. Song C., Earley B., Leonard B.E. The effects of central administration of neuropeptide Y on behavior, neurotransmitter, and immune functions in the olfactory bulbectomized rat model of depression. Brain Behavior and Immunity. 10(1):1996;1-16.
89. Kronfol Z., House J.D. Lymphocyte mitogenesis, immunoglobulin and complement levels in depressed patients and normal controls. Acta Psychiatrica Scandinavica. 80(2):1989;142-147.
90. Holmes P.V., Davis R.C., Masini C.V., Primeaux S.D. Effects of olfactory bulbectomy on neuropeptide gene expression in the rat olfactory/limbic system. Neuroscience. 86(2):1998;587-596.
91. Primeaux S.D., Holmes P.V. Olfactory bulbectomy increases met-enkephalin- and neuropeptide Y-like immunoreactivity in rat limbic structures. Pharmacology Biochemistry and Behavior. 67(2):2000;331-337.
92. Jimenez-Vasquez P.A., Mathé A.A., Thomas J.D., Riley E.P., Ehlers C.L. Early maternal separation alters neuropeptide Y concentrations in selected brain regions in adult rats. Developmental Brain Research. 131(1-2):2001;149-152.
93. Kaufman J., Charney D. Effects of early stress on brain structure and function: implications for understanding the relationship between child maltreatment and depression. Developmental Psychopathology. 13(3):2001;451-471.
94. Addario D. Developmental considerations in the concept of affective illness. Journal of Clinical Psychiatry. 46(10Pt2):1985;46-56.
95. Ladd C.O., Huot R.L., Thrivikraman K.V. Long-term behavioural and neuroendocrine adaptations to early experience. Progress in Brain Research: The Biological Basis for Mind Body Interactions. 2000;70-101 Elsevier, Amsterdam.
96. Hofer M.A. Early social relationships: a psychobiologists view. Child Development. 58:1987;633-647.
97. Kaufman J., Plotsky P.M., Nemeroff C.B., Charney D.S. Effects of early adverse experiences on brain structure and function: clinical implications. Biological Psychiatry. 48(8):2000;778-790.
98. Stogner K.A., Holmes P.V. Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats. European Journal of Pharmacology. 387(2):2000;R9-R10.
99. Redrobe J.P., Dumont Y., Fournier A., Quirion R. The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test. Neuropsychopharmacology. 26(5):2002;615-624.
100. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Archives Internationales de Pharmacodynamie et de Therapie. 229(2):1977;327-336.
101. Widerlov E., Lindstrom L.H., Wahlestedt C., Ekman R. Neuropeptide Y and peptide YY as possible cerebrospinal markers for major depression and scizophrenia respectively. Journal of Psychiatric Research. 22(1):1988;69-79.
102. Heilig M., Widerlov E. Neuropeptide Y: an overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnesses. Acta Psychiatrica Scandinavica. 82(2):1990;95-114.
103. Hashimoto H., Onishi H., Koide S., Kai T., Yamagami S. Plasma neuropeptide Y in patients with major depressive disorder. Neuroscience Letters. 216(1):1996;57-60.
104. Nilsson C., Karlsson G., Blennow K., Heilig M., Ekman R. Differences in the neuropeptide Y-like immunoreactivity of the plasma and platelets of human volunteers and depressed patients. Peptides. 17(3):1996;359-362.
105. Berrettini W.H., Doran A.R., Kelsoe J., Roy A., Pickar D. Cerebrospinal fluid neuropeptide Y in depression and schizophrenia. Neuropsychopharmacology. 1(1):1987;81-83.
106. Widdowson P.S., Ordway G.A., Halaris A.E. Reduced neuropeptide Y concentrations in suicide brain. Journal of Neurochemistry. 59(1):1992;73-80.
107. Ordway G.A., Stockmeier C.A., Meltzer H.Y., Ocerholser J.C., Jaconetta S., Widdowson P.S. Neuropeptide Y in frontal cortex is not altered in major depression. Journal of Neurochemistry. 65(4):1995;1646-1650.
108. Mathé A.A., Rudorfer M.V., Stenfors C., Manji H.K., Potter W.C., Theodorsson E. Effect of electroconvulsive treatment on somatostatin, neuropeptide Y, endothelin and neurokinin A concentrations in cerebrospinal fluid of depressed patients. Depression. 3:1996;250-256.
109. Caberlotto L., Hurd Y.L. Neuropeptide Y Y1 and Y2 receptor mRNA expression in the prefrontal cortex of psychiatric subjects. Neuropsychopharmacology. 25(1):2001;91-97.
110. Caberlotto L., Fuxe K., Sedvall G., Hurd Y.L. Localization of neuropeptide Y Y1 mRNA in the human brain: abundant expression in cerebral cortex and striatum. European Journal of Neuroscience. 9(6):1997;1212-1225.
111. Westrin A., Ekman R., Traskman-Bendz L. Alterations in corticotropin releasing hormone (CRH) and neuropeptide Y (NPY) plasma levels in mood disorder patients with a recent suicide attempt. European Neuropsychopharmacology. 9(3):1999;205-211.
112. Westrin A., Engstom G., Ekman R., Traskman-Bendz L. Correlations between plasma-neuropeptides and temperament dimensions differ between suicidal patients and healthy controls. Journal of Affective Disorders. 49(1):1998;45-54.
113. Detera-Wadleigh S.D., de Miguel C., Berrettini W.H., DeLisi L.E., Goldin L.R., Gershon E.S. Neuropeptide Y gene polymorphisms in affective disorder and schizophrenia. Journal of Psychiatric Research. 21(4):1987;581-587.
114. Erickson J.C., Clegg K.E., Palmiter R.D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature. 381(6581):1996;415-421.
115. Bannon A.W., Seda J., Carmouche M., Francis J.M., Norman M.H., Karbon B., McCaleb M.L. Behavioral characterization of neuropeptide Y knockout mice. Brain Research. 868(1):2000;79-87.
116. Pedrazzini T., Seydoux J., Kunstner P., Aubert J.F., Grouzmann E., Beermann F., Brunner H.R. Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor. Nature Medicine. 4(6):1998;722-726.
117. Smith-White M.A., Herzog H., Potter E.K. Role of neuropeptide Y Y(2) receptors in modulation of cardiac parasympathetic neurotransmission. Regulatory Peptides. 103(2-3):2002;105-111.
118. Baldock P.A., Sainsbury A., Couzens M., Enriquez R.F., Thomas G.P., Gardiner E.M., Herzog H. Hypothalamic Y2 receptors regulate bone formation. Journal of Clinical Investigation. 109(7):2002;915-921.
119. Marsh D.J., Hollopeter G., Kafer K.E., Palmiter R.D. Role of Y5 neuropeptide Y receptor in feeding and obesity. Nature Medicine. 4(6):1998;718-721.
120. Michalkiewicz M., Michalkiewicz T., Kreulen D.L., McDougall S.J. Increased blood pressure in neuropeptide Y transgenic rats. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology. 281(2):2001;R417-R426.
121. Thorsell A., Michalkiewicz M., Dumont Y., Quirion R., Caberlotto L., Mathé A.A., Heilig M. Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y over-expression. Proceedings of the National Academy of Science USA. 97(23):2000;12852-12857.
122. Austin M.P., Mitchell P., Goodwin G.M. Cognitive deficits in depression: possible implications for functional neuropathology. British Journal of Psychiatry. 13(3):2001;451-471.